NEW YORK - TelAve -- New York, NY, – Age Reversal Unity is calling attention to the FDA's failure to respond to its citizen petition, submitted on May 22, 2024, requesting that aging be classified as a disease. The FDA was required to respond within 180 days but has yet to do so.

The petition advocates for the recognition of aging as a medical condition that could benefit from targeted research and treatments. By classifying aging as a disease, Age Reversal Unity believes more resources, funding, and regulatory support could be directed toward innovative solutions for age-related health issues, potentially improving the lives of millions of aging Americans.

"The FDA's delay in responding to this petition is a setback in the fight against age-related diseases," said Age Reversal Unity. "Recognizing aging as a disease would empower researchers to develop life-changing treatments, and we urge the FDA to act immediately."

More on TelAve News

• Paul E. Saperstein Co. Announces Geographic Expansion of Auction Services
• Florida Broker Bent Danholm Featured in the Daily Mail's U.S. Real Estate Coverage
• Robin Launches Legal Intelligence Platform to solve intelligence gap in Fortune 500 legal teams
• Melissa B. Releases Digitally Independent: Empowering Music Artists with AI and Brand Strategy
• Consumer Accountability Alliance Issues Formal Notice Alleging Proximate Liability for Medical Harm

Aging is the primary risk factor for major diseases like Alzheimer's, cardiovascular disease, and cancer. Age Reversal Unity argues that addressing aging could unlock new pathways for medical advancements and improve public health.

The company calls on the FDA to fulfill its legal obligation and respond to the petition, which has received widespread support from experts in aging research.

For more information about Age Reversal Unity and its ongoing efforts to promote age-related research and policy, please visit this link agereversalunity.com